Tabula Rasa HealthCare, Inc.
NASDAQ:TRHC
10.5 (USD) • At close November 2, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 299.516 | 331.26 | 297.219 | 284.707 | 204.27 | 134.546 | 94.062 | 70.039 | 48.428 | 25.143 |
| Cost of Revenue
| 232.603 | 233.356 | 204.812 | 181.355 | 137.669 | 93.655 | 65.177 | 49.128 | 37.812 | 20.921 |
| Gross Profit
| 66.913 | 97.904 | 92.407 | 103.352 | 66.601 | 40.891 | 28.885 | 20.911 | 10.616 | 4.222 |
| Gross Profit Ratio
| 0.223 | 0.296 | 0.311 | 0.363 | 0.326 | 0.304 | 0.307 | 0.299 | 0.219 | 0.168 |
| Reseach & Development Expenses
| 14.483 | 19.791 | 18.18 | 21.739 | 12.222 | 5.628 | 3.811 | 2.877 | 1.66 | 1.338 |
| General & Administrative Expenses
| 74.974 | 73.759 | 65.378 | 50.897 | 28.181 | 21.181 | 11.831 | 7.115 | 3.97 | 2.482 |
| Selling & Marketing Expenses
| 10.491 | 25.969 | 21.547 | 25.273 | 9.667 | 5.542 | 3.86 | 2.88 | 2.272 | 1.775 |
| SG&A
| 85.465 | 99.728 | 86.925 | 76.17 | 37.848 | 26.723 | 15.691 | 9.995 | 6.242 | 4.257 |
| Other Expenses
| 23.347 | 47.706 | 45.04 | 34.276 | 16.802 | 0 | 0.639 | 0 | 0 | 0 |
| Operating Expenses
| 123.295 | 167.225 | 150.145 | 132.185 | 66.872 | 41.863 | 24.617 | 16.805 | 9.719 | 6.713 |
| Operating Income
| -56.382 | -69.321 | -57.738 | -28.833 | -49.739 | 5.201 | 4.551 | 6.165 | 0.107 | -2.491 |
| Operating Income Ratio
| -0.188 | -0.209 | -0.194 | -0.101 | -0.243 | 0.039 | 0.048 | 0.088 | 0.002 | -0.099 |
| Total Other Income Expenses Net
| -20.563 | -9.107 | -28.396 | -19.802 | -49.468 | 6.173 | -5.489 | -0.727 | -1.059 | -0.547 |
| Income Before Tax
| -76.945 | -78.428 | -86.134 | -48.635 | -50.645 | 4.513 | -5.709 | -2.536 | -1.516 | -3.871 |
| Income Before Tax Ratio
| -0.257 | -0.237 | -0.29 | -0.171 | -0.248 | 0.034 | -0.061 | -0.036 | -0.031 | -0.154 |
| Income Tax Expense
| 0.389 | 0.627 | -5.168 | -16.199 | -3.376 | -9.783 | 0.541 | 0.328 | -0.409 | 0.833 |
| Net Income
| -77.334 | -79.055 | -80.966 | -32.436 | -47.269 | 14.296 | -6.25 | -2.864 | -1.107 | -3.871 |
| Net Income Ratio
| -0.258 | -0.239 | -0.272 | -0.114 | -0.231 | 0.106 | -0.066 | -0.041 | -0.023 | -0.154 |
| EPS
| -3.18 | -3.39 | -3.71 | -1.57 | -2.48 | 0.76 | -0.83 | -0.29 | -0.11 | -0.39 |
| EPS Diluted
| -3.18 | -3.39 | -3.71 | -1.57 | -2.48 | 0.68 | -0.54 | -0.29 | -0.11 | -0.39 |
| EBITDA
| -24.64 | -21.615 | -12.698 | 5.443 | 16.531 | 8.54 | 9.383 | 8.039 | 2.714 | -1.373 |
| EBITDA Ratio
| -0.082 | -0.065 | -0.043 | 0.019 | 0.081 | 0.063 | 0.1 | 0.115 | 0.056 | -0.055 |